Cytomegalovirus retinitis and viral resistance: Ganciclovir resistance

Journal of Infectious Diseases

Volumn 177, Issue 3, 1998, Pages 770-773

  Jabs, Douglas A ^a,b   Enger, Cheryl ^a   Dunn, J P ^a   Forman, Michael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FOLLOW UP; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETINITIS; URINE CULTURE; VIRUS CULTURE; VISUAL IMPAIRMENT;

EID: 0031932271     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514249     Document Type: Article

References (15)

1. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989;107:75-80.
2. Hoover DR, Peng Y, Saah A, et al. Occurrence of Cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 1996;114:821-7.
3. Spector SA, Weingeist T, Pollard RB, et al. A randomized, controlled study of intravenous ganciclovir therapy for Cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis 1993;168:557-63.
4. Drew WL, Ives D, Lalezari JP, et al. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med 1995;333:615-20.
5. Martin DF, Parks DJ, Mellow SD, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 1994;112:1531-9.
6. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial: 4. visual outcomes. Ophthalmology 1994;101:1250-61.
7. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. Ann Intern Med 1997;126:264-74.
8. Drew WL, Miner RC, Busch DF, et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 1991;163:716-9.
9. Dunn JP, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol 1995; 119:587-96.
10. Jabs DA, Dunn JP, Enger C, et al. Cytomegalovirus retinitis and viral resistance: prevalence of resistance at diagnosis, 1994. Arch Ophthalmol 1996;114:809-14.
11. Dankner WM, Scholl D, Stanat SC, Martin M, Sonke RL, Spector SA. Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus. J Virol Methods 1990;28:293-8.
12. Drew WL, Miner RC, Saleh E. Antiviral susceptibility of cytomegalovirus: criteria for detecting resistance to antivirals. Clin Diagn Virol 1993;1: 179-85.
13. Arevalo JF, Gonzalez C, Capparelli EV, et al. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 1995; 172:951-6.
14. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 1995;172:239-42.
15. Sullivan V, Biron KK, Talarico C, et al. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob Agents Chemother 1993;37:19-25.